Search

everythinglearnresearchcommunity

for

Search:↓

Laser treatment and synovial fluid can change hair follicle cells to resemble joint cells, with the changes being more significant when both treatments are used together.

A hydrogel releasing pectolinarin speeds up wound healing and reduces scarring.

Lack of Ctip2 in skin cells delays wound healing and disrupts hair follicle stem cell markers in mice.

Platelet-rich plasma may improve hair density in androgenetic alopecia patients.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

Oral cyclosporin doesn't stop hair loss.

A man developed skin issues from cancer medication, which improved with specific treatments.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Reflectance confocal microscopy can tell apart white dots on the scalp as either sweat gland ducts or hair follicle openings.

A new mutation in the K6b gene caused a girl's late-appearing nail condition.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

The conclusion introduces a new way to classify skin cysts using their shape and genetic markers.

Electrical epilation damages hair follicles and surrounding skin, likely preventing hair regrowth.

Skin symptoms can indicate endocrine disorders and have various treatments.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Melanocyte development from neural crest cells is complex and influenced by many factors, and better understanding could help treat skin disorders.

Platelet-Rich Plasma (PRP) increases the number of new hair follicles and speeds up hair formation.

Glutamine metabolism affects hair stem cell maintenance and their ability to change back to stem cells.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.